"PRRT: What We Know, Special Considerations & Clinical Trials" with Dr. Strosberg • Jan 11, 2024
Рет қаралды 1,931
6 ай бұрынLearn the latest on PRRT with NET expert Dr. Jonathan Strosberg. Dr Strosberg was the principal investigator of the NETTER-1 study which led to the FDA approval of Lutathera and has authored numerous articles on PRRT. He will discuss the latest in PRRT, including special considerations and current clinical trials.
Visit LACNETS.org for more information.
@virginiasmith5371 4 ай бұрын
I had difficult side effects after receiving octreotide injection: hallucinations, diarrhea, high blood pressure. What do I have to avoid in continued therapies?
@zacharycat603 2 ай бұрын
I had rather severe pain during and after the injections. Then before the last one the nurse warmed the medicine rather than injecting it cold, and I felt no pain or after effects. No idea that such a small thing could make so much difference.
AnythingAlexia
Рет қаралды 24 МЛН
Moffitt Cancer Center
Рет қаралды 1,5 М.
Leukemia & Lymphoma Society of Canada
Рет қаралды 11 М.
NETRF
Рет қаралды 1,8 М.
Moffitt Cancer Center
Рет қаралды 3,8 М.